Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-15 of 15
Keywords: Plasma
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Patient Plasma Management
Open Access
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2025) 52 (2): 111–113.
Published Online: 28 March 2025
..., instructions or products referred to in the content or advertisements. 2025 Plasma Transfusion Fresh frozen plasma and plasma-derived clotting factors are cornerstones of the transfusion therapy to resolve dysbalances in coagulation. Early transfusion of plasma could reduce mortality...
Journal Articles
Challenges for Plasma-Derived Medicinal Products
Open Access
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2023) 50 (2): 116–122.
Published Online: 12 April 2023
...Paul F.W. Strengers Background: Plasma-derived medicinal products (PDMPs) are medicinal products derived from human plasma, and a number of PDMPs are listed on the WHO Model List of Essential Medicines. These and other PDMPs are crucial for the prophylaxis and treatment of patients with immune...
Journal Articles
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2021) 48 (6): 377–380.
Published Online: 02 November 2021
..., instructions or products referred to in the content or advertisements. Trauma Resuscitation Whole blood Transfusion Plasma The only constant in life is change Heraclitus Dear Editor, That quotation is so true, is it not? Think back to when a physician was on call in the 1980s...
Journal Articles
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2021) 48 (6): 358–365.
Published Online: 14 October 2021
...Bryon P. Jackson; Jason L. Sperry; Mark H. Yazer Background: Early initiation of blood products transfusion after injury has been associated with improved patient outcomes following traumatic injury. The ability to transfuse patients’ plasma in the prehospital setting provides a prime opportunity...
Journal Articles
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections
Open AccessEnrico Richter, Doaa Al Arashi, Bianca Schulte, Christian Bode, Benjamin Marx, Souhaib Aldabbagh, Celina Schlüter, Beate Mareike Kümmerer, Johannes Oldenburg, Markus B. Funk, Christian Putensen, Ricarda Maria Schmithausen, Gunther Hartmann, Anna Eis-Hübinger, Hendrik Streeck
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2021) 48 (3): 154–160.
Published Online: 25 May 2021
... found that their neutralizing capacity was disproportionately increased ( p < 0.001). Conclusion: Our observations support the hypothesis that there are no potential hazards from blood or plasma transfusion of SARS-CoV-2-positive individuals with mild flu-like symptoms and more importantly...
Journal Articles
Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung Injury
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2014) 41 (3): 172–175.
Published Online: 12 May 2014
...Teresa Jimenez-Marco; Daniel Ruiz-Alderton; Antonia M. Bautista-Gili; Enrique Girona-Llobera Introduction: Risk reduction strategies for transfusion-related acute lung injury (TRALI) include the preferential use of male donors to provide fresh frozen plasma (FFP). Implementing this measure based...
Journal Articles
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System TM
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2011) 38 (1): 19–31.
Published Online: 27 January 2011
..., a comprehensive pre-clinical and clinical development and an ongoing hemovigilance program. Material and Methods: The INTERCEPT Blood System utilizes amotosalen and UVA light and enables for the treatment of platelets and plasma in the same device. Preclinical studies of pathogen inactivation and toxicology...
Journal Articles
UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2011) 38 (1): 43–54.
Published Online: 22 January 2011
... been developed and is under clinical evaluation for its efficacy and safety. In addition, proof of principle has been shown for UVC treatment of plasma units. The pathogen reduction process is based on application of UVC light of a specific wavelength (254 nm) combined with intense agitation...
Journal Articles
Quarantine Plasma: Quo vadis?
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Transfus Med Hemother (2010) 37 (3): 118–122.
Published Online: 25 May 2010
...W. Kurt Roth Upon the introduction of mandatory nucleic acid amplification technology (NAT) testing in Germany for HCV, quarantining of fresh frozen plasma (FFP) was reduced in 2002 from 6 to 4 months. In 2004 HIV-1 NAT and in 2005 anti-HBc testing were introduced to further reduce the residual...
Journal Articles
Wirkung verschiedener Plasmapräparationen und i.v.-Immunglobuline auf die Funktion von Lymphozyten und Monozyten in vitro
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1992) 19 (5): 232–236.
Published Online: 27 May 2009
... Kolonkarzinoms von transfundiertem Blut negativ beeinflußt wird. Besonders Plasma steht im Verdacht, immunsuppressiv zu wirken. Wir untersuchten deshalb in vitro die Wirkung von Frischplasma (FP), gefrorenem Frischplasma (GFP) und Heparin-Plasma (HP) sowie von verschiedenen i.v.-Immunglobulinen (IVIG) auf die...
Journal Articles
Transfusionsassoziierte HIV-Infektion
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1994) 21 (Suppl. 1): 7–10.
Published Online: 27 May 2009
... to in the content or advertisements. Blut Plasma Virusinfektionen Transfusionssicherheit Inaktivierung HIV 27 5 2009 ...
Journal Articles
Möglichkeiten der Virusinaktivierung von gepooltem Frischplasma mit Tri-n-butylphosphat-(TNBP-)Detergenz (SD-Verfahren)
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1994) 21 (Suppl. 1): 77–79.
Published Online: 27 May 2009
... Herpesgruppe (Cytomegalievirus, Epstein-Barr-Virus), werden ebenfalls inaktivert. Bei hüllenlosen Viren, wie z. B. Parvovirus B19 oder Picornaviren, hat das SD-Verfahren seine Grenzen, d.h., diese Viren werden nicht inaktiviert. In Blutkomponenten wie Plasma und Blutprodukten wird in Zukunft das SD-Verfahren...
Journal Articles
Anti-Lipopolysaccharide-Immunoglobulin (IgG-Anti-LPS) Therapy in Intensive Care Patients Following Surgery from Infectious Disease
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Infusionstherapie (1990) 17 (4): 220–223.
Published Online: 26 May 2009
... frozen plasma was administered during the first 5 postoperative days, containing either more than 65 μg/ml Anti-LPS in the therapy group or less than 12.5 μg/ml in the control group. The serum level of Anti-LPS was monitored. Clinical and chemical parameters were recorded to evaluate infectious...
Journal Articles
Erste Erfahrungen mit Methylenblau-Virus-inaktiviertem Fresh-Frozen-Plasma: Ergebnisse einer klinischen und einer In-vitro-Studie
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1992) 19 (2): 84–90.
Published Online: 26 May 2009
...J.U. Wieding; H. Neumeyer Methylenblau (MB) wird seit kurzem zur Inaktivierung von Viren in Fresh-Frozen-Plasma-Einheiten (FFP) von Einzelspendern eingesetzt. In einer ersten klinischen Studie wurden 519 Einheiten eines Methylenblau-behan-delten Plasmas (MB-FFP) an 103 Patienten gegeben. Dabei...
Journal Articles
A New Approach to Evaluate the Final Effect of Parenteral Nutrition
Available to Purchase
Journal:
Transfusion Medicine and Hemotherapy
Infusionstherapie und klinische Ernährung (1975) 2 (3): 182–185.
Published Online: 14 May 2009
...V. Kudlička; P. Doberský; V. Kudličková In patients who had undergone gastric operations, the efficacy of a parenteral rehabilitation with plasma, human albumin and Amino-fusin® L forte was determined by assessing the extravascular albumin pool. The intravenous administration of Aminofusin® L forte...